Effect of Enhanced External Counterpulsation (EECP) on Subclinical Atherosclerosis

NCT01106495 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Atherosclerosis

Interventions

DEVICE: Enhanced External Counterpulsation (EECP)
DRUG: Simvastatin

Sponsor

Sun Yat-sen University